A novel monoclonal antibody to characterize pathogenic polymers in liver disease associated with alpha1-antitrypsin deficiency.
Alpha(1)-antitrypsin is the most abundant circulating protease inhibitor. The severe Z deficiency allele (Glu342Lys) causes the protein to undergo a conformational transition and form ordered polymers that are retained within hepatocytes. This causes neonatal hepatitis, cirrhosis, and hepatocellular carcinoma. We have developed a conformation-specific monoclonal antibody (2C1) that recognizes the pathological polymers formed by alpha(1)-antitrypsin. This antibody was used to characterize the Z variant and a novel shutter domain mutant (His334Asp; alpha(1)-antitrypsin King's) identified in a 6-week-old boy who presented with prolonged jaundice. His334Asp alpha(1)-antitrypsin rapidly forms polymers that accumulate within the endoplasmic reticulum and show delayed secretion when compared to the wild-type M alpha(1)-antitrypsin. The 2C1 antibody recognizes polymers formed by Z and His334Asp alpha(1)-antitrypsin despite the mutations directing their effects on different parts of the protein. This antibody also recognized polymers formed by the Siiyama (Ser53Phe) and Brescia (Gly225Arg) mutants, which also mediate their effects on the shutter region of alpha(1)-antitrypsin.


CONCLUSIONS
Z and shutter domain mutants of alpha(1)-antitrypsin form polymers with a shared epitope and so are likely to have a similar structure.
Miranda
Elena
E
Department of Medicine, University of Cambridge, Cambridge Institute for Medical Research, Wellcome Trust/Medical Research Council Building, Cambridge, UK. mariaelena.mirandabanos@uniroma1.it
Pérez
Juan
J
Ekeowa
Ugo I
UI
Hadzic
Nedim
N
Kalsheker
Noor
N
Gooptu
Bibek
B
Portmann
Bernard
B
Belorgey
Didier
D
Hill
Marian
M
Chambers
Susan
S
Teckman
Jeff
J
Alexander
Graeme J
GJ
Marciniak
Stefan J
SJ
Lomas
David A
DA
D000911:Antibodies, Monoclonal / Q000276:immunology*; D000918:Antibody Specificity; D004721:Endoplasmic Reticulum / Q000378:metabolism; D000939:Epitopes / Q000276:immunology; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007567:Jaundice, Neonatal / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008107:Liver Diseases / Q000378:metabolism*; D008297:Male; D009154:Mutation / Q000235:genetics; D011108:Polymers / Q000378:metabolism*; D017434:Protein Structure, Tertiary; D000515:alpha 1-Antitrypsin / Q000235:genetics / Q000276:immunology* / Q000378:metabolism*; D019896:alpha 1-Antitrypsin Deficiency / Q000378:metabolism*
D000911:Antibodies, Monoclonal; D000939:Epitopes; D011108:Polymers; D000515:alpha 1-Antitrypsin